Announcements

2 May 2024
MDPI Insights: The CEO's Letter #11 - 2023 Annual Report, MDPI Awards, STM

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

2023 Annual Report

This is an exciting time of year at MDPI, as we have just released our annual report 2023, recapping the past year and sharing the progress and changes that took place during it.


Stefan Tochev (CEO, MDPI)

Reflecting on 2023, I can't help but think of the changes that have occurred not only at MDPI but also within our industry as a whole. In light of this, I’m reminded that change is the only constant, and that for a publishing enterprise that has experienced rapid growth, adapting to change becomes not only a necessity but also a catalyst for sustained success.

Looking back on the significant ground we covered in 2023, I am pleased to report that the year was marked by a rise in paper submissions, along with a range of initiatives aimed at improving our internal processes and delivering top services to our scientists.

2023 Top-line MDPI Numbers

An important priority for 2023 was to strengthen our editorial policies. Despite a notable increase in the number of papers submitted from 603,000 to 655,000 (+8.6%), there was a decrease in the number of papers published from 303,000 to 285,000 (-5.9%), consistent with the overall trend in the scholarly publishing market. MDPI’s market share in gold open access articles published reached 17% in 2023 (according to Dimensions data).

2023 Open Access Numbers

For over two decades, MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020. This trajectory is deeply rooted in our history and reflects our unwavering commitment to, and vision for, an open future. This momentum continued in 2023, with 39% of the 4.16 million articles and reviews published as gold full-OA, 15% as gold hybrid-OA, 8% as bronze-OA, and 3% as green-OA, relative to 35% behind a paywall. In terms of gold OA (full or hybrid) articles and reviews published, MDPI leads the way in terms of total articles published in 2023.

MDPI is the trusted and preferred OA publisher for the scholarly community

However, in 2023, we saw a downward trend in publication numbers compared to 2022. This trend was also seen in total OA publications. While the number of submissions increased, the decline in MDPI publications can be attributed to several factors, such as improved scrutiny in our peer-review process, including the evaluation of content scope and higher rejection rates, and a post-pandemic decrease in research related to COVID-19 papers.

Download 2023 MDPI Annual Report.
Access 2023 Digital Report.

Impactful Research

Recognizing Scholars – MDPI Awards

MDPI is committed to empowering young researchers as they embark on their careers. In 2023, our journals hosted a total of 400 awards, receiving 8,839 applications and nominations. The evaluation committees selected 959 winners, with the total budget for these awards amounting to CHF 546,500.

For more information about MDPI awards, applications, and winners, please click here

The following awards recognize scholars and the impact of their research, including Young Investigator Awards, Best PhD Thesis Awards, and Travel Awards for junior researchers.

MDPI Awards – The following awards require an application or a nomination.

Young Investigator Award (CHF 1000–2000 for each winner)
This award acknowledges the achievements of young investigators in research areas relevant to the journal’s scope. Candidates must have received their PhD no more than 10 years prior to the award announcement date and must be nominated.

Best PhD Thesis Award (CHF 500–800 for each winner)
This award recognizes young scholars who have completed outstanding PhD theses in research areas relevant to the journal’s scope. It aims to encourage them to continue their excellent work and make further contributions to their field.

Travel Award (CHF 500–800 for each winner)
This award encourages junior scientists to present their latest research at academic conferences relevant to the journal’s scope, thereby increasing their impact.

Distinguished Scholars
Additionally, 220 awards were granted to the most distinguished authors and reviewers in our journals through Best Paper Awards and Outstanding Reviewer Awards. The following awards are selected by the editorial staff of the journal and do not require an application or a nomination. They exemplify the excellent contributions made by our authors, reviewers, and editors.

These awards exemplify the excellent contributions made by our authors, reviewers, and editors

Best Paper Award (CHF 200–500 for each winner)
This award is granted annually to highlight publications of high quality, scientific significance, and extensive influence.

Outstanding Reviewer Award (CHF 500 for partial winners)
This award is given annually to recognize reviewers who generously contribute their time to reviewing papers and demonstrate thoroughness, professionalism, and timeliness in their reviews.

MDPI also offers awards for specific topics in various research fields:

Carbon Neutrality Award (CHF 500–800 for each winner)
Sponsored by MDPI journal Sustainability, this award recognizes applicants who have made exceptional academic or societal contributions to carbon neutrality, either in general or in relation to a specific carbon-neutrality-related issue.

Intelligent Manufacturing Award (CHF 500–800 for each winner)
Administered by MDPI journal Machines, this award is presented to an individual who has made outstanding academic or societal contributions to the field of intelligent manufacturing.

Granted: World Sustainability Awards

Inside MDPI

MDPI Opens Office in Seoul, Korea and Appoints Claude Seo as Office Manager

As CEO of the world’s leading OA publisher, I am pleased to announce the official opening of our Korean branch office. With this addition, MDPI now operates 21 offices in 12 countries worldwide, improving on our position as a truly global publisher. This expansion represents more than just an increase in our physical footprint; it is a pivotal step in our ongoing commitment to making scientific knowledge more accessible across the globe.

MDPI now operates 21 offices in 12 countries worldwide, improving on our position as a truly global publisher


Claude Seo (MDPI Korea Office Manager, Seoul)

Claude Seo, who has over 15 years of experience in the academic publishing industry, has been appointed as the Office Manager of the Seoul office. The launch of our Seoul office allows us to better support the Korean scientific community and to further promote the publication of OA journals in the region.

Reflecting on his role, Claude shared that he is:

“Delighted to have been entrusted with this position within MDPI, the no. 1 scholarly OA publisher. As we establish our presence in Korea, we are dedicated to integrating ourselves into the local community and contributing to its vibrant culture. Our commitment goes beyond business growth; it is about creating a more informed and innovative society by embracing and promoting diversity within the scientific community.”

Sungkyunkwan University Joins MDPI’s Institutional Open Access Program

Additionally, I am pleased to share that Sungkyunkwan University has joined MDPI’s Institutional Open Access Program (IOAP). This program offers free access to MDP’s online submission system for institutions and provides APC discounts to affiliated authors. Thirteen major Korean universities, including Sungkyunkwan University, Kyunghee University, Chung-Ang University, and the Catholic University of Korea, have adopted IOAP in Korea.

Learn more about MDPI’s collaboration in Korea in my previous CEO Letter, in which I recap our visit to Seoul, South Korea.

Coming Together for Science

4th MMCS: Harnessing the Power of New Drug Modalities

Our conference team successfully managed the 4th Molecules Medicinal Chemistry Symposium, held from 24–26 April in Barcelona, Spain. It was chaired by Prof. Dr. Diego Muñoz-Torrero from the Institute of Biomedicine (IBUB), University of Barcelona, Spain, and Prof. Dr. Simona Collina from the University of Pavia, Italy. In total, there were 84 accepted abstracts and 102 conference attendees from 22 different countries.


From left to right: Prof. Dr. Rino Ragno (Scientific Committee), Dr. Maria Emilia Sousa (Scientific Committee), Prof. Dr. Claudio Viegas Jr. (Scientific Committee), Prof. Dr. Simona Collina (Chair), Prof. Dr. Diego Muñoz-Torrero (Chair), Alvina Wu (Managing Editor, MDPI), Prof. Dr. Roman Dembinski (Scientific Committee), Prof. Dr. Mariana Spetea (Scientific Committee).

The event comprised 12 Invited Speakers, 35 Selected Talks, 10 Flash Poster Presentations, and 39 Posters. The overarching topic of the conference was the impact of the emergence of new drug modalities on drug discovery, with thematic sessions covering topics such as photoactivatable drugs, candidates targeting RNA and epigenetic targets, covalent modifiers, and the development of new anti-cancer agents, among other medicinal chemistry projects.

We are pleased to have received feedback from attendees highlighting the professional approach of the conference chairs and participants, the high quality of the talks, and the overall outstanding organization on the part of the MDPI conference team.

Thank you to the conference sponsors, Fluorochem and IBUB, and to our partnering societies, The Spanish Society for Biochemistry and Molecular Biology (SEBBM), and the Spanish Society of Medicinal Chemistry (SEQT).

Upcoming In-Person Event

28–31 May, 2024
Polymers 2024 – Polymers for a Safe and Sustainable Future
Location:
Athens, Greece
Conference Chairs: Prof. Dr. Dimitrios Bikiaris, Prof. Dr. Konstantinos Triantafyllidis, Dr. Ioanna Deligkiozi
We look forward to welcoming experts Prof. Damià Barceló, Prof. Minna Hakkareinen, and Prof. Armando J. D. Silvestre to this event.

Find more upcoming MDPI events here.

Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

A Report from the Future – STM US Annual Conference 2024


Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli and Dr. Ioana Craciun from MDPI’s Scientific Office Board.

MDPI has for a long time been a sponsor of the STM Annual Conferences, held yearly in the US and Frankfurt, and is a trusted partner and supporter of the STM organization. While I have attended the Frankfurt conference for the past three years, this was my first time visiting the Washington, DC session, and I am glad I did.

Although it was a brief trip, I greatly appreciated the opportunity to attend in the company of my colleagues Dr. Giulia Stefenelli and Dr. Ioana Craciun from MDPI’s Scientific Office Board. They always help map some of the new industry trends against MDPI’s operational framework and guidelines. It’s a great group for kicking ideas back and forth on what we can apply at MDPI.

In my experience, STM never fails to deliver. It’s always a great conference for reconnecting with fellow publishers, industry friends, and vendors. As usual, STM this year curated a diverse range of speakers and panels, who proferred valuable knowledge and insights from outside our industry, delivering thought-provoking insights into our field. An example of this was the ‘Trust Panel’ session, which included Alan Schiffres (Managing Director, InfoLinx), who shared a number of the learnings about fraud and risk management from his 40 years in financial services, to help address some of the challenges we are currently facing in the area of publishing integrity.

Launch of STM Trends 2028 Panel

I particularly enjoyed the ‘Launch of STM Trends 2028 Panel’, which presented a report focused on the integration of humans and machines in scholarly publishing. The session highlighted themes such as AI, digitization, and the evolving research ecosystem. The report envisions a future where technology blurs the lines between human and machine involvement in research processes, with significant implications for trust, reputation, and equity. While this presents opportunities for connectivity and knowledge dissemination, it also poses challenges such as disinformation, fragmentation, and geopolitical tensions. We must rely on a wise combination of technology and human agency to navigate this complex landscape and will have to carefully examine its potential impacts on communication and scholarly publishing.

MDPI has joined the STM Integrity Hub. Click here to learn more.

While every presenter brought their own knowledge and personal touch, I was particularly pleased to encounter new speakers such as Heather Whitney (Research Assistant Professor, Radiology, University of Chicago) and Igor Grossmann (Professor of Psychology, University of Waterloo, Canada). Having studied Sociology at the University of Guelph, I have a soft spot for fellow social scientists from Canada, and I was very impressed by Igor’s presentation on ‘The Social Scientist: A View from the Future’ and his participation in the panel session ‘The Future Beyond the Article,’ which was one of my favourites from the conference, given the diversity of perspectives from the panel speakers.

Memorial Park in Washington, DC

On a personal note, this was my first-time visiting Washington, DC, and I’m glad we took an afternoon to visit the Memorial Park, with its incredible monuments to figures ranging from Martin Luther King, Jr. to Abraham Lincoln. The magnitude of the monuments is deeply impressive. I particularly appreciated the Thomas Jefferson memorial and the following quote, which I think speaks to the importance of change and adaptation. It’s something we can apply not only in our industry but also in our personal lives.

"I am not an advocate for frequent changes in laws and constitutions, but laws and institutions must go hand in hand with the progress of the human mind. As that becomes more developed, more enlightened, as new discoveries are made, new truths discovered and manners and opinions change, with the change of circumstances, institutions must advance also to keep pace with the times. We might as well require a man to wear still the coat which fitted him when a boy as a civilized society to remain ever under the regimen of their barbarous ancestors."

– Excerpted from a letter to Samuel Kercheval, July 12, 1816.

Stefan Tochev
Chief Executive Officer
MDPI AG

30 April 2024
MDPI Opens Office in Seoul, Korea and Appoints Claude Seo as Office Manager

MDPI, the leading Open Access (OA) publisher, announced on Monday that it opened its Korean branch office on 29th April 2024. With this addition, MDPI now operates 21 offices in 12 countries worldwide. Claude Seo, with over 20 years of experience in the academic journal publishing industry, including Nature Publishing Group (NPG), has been appointed as the Office Manager of the Seoul office.

With the establishment of a Seoul office, MDPI aims to actively support Korea scientific communities to further promote the publication of OA journals in the region. As of the end of 2023, Korea ranked sixth worldwide in both submissions and publications of MDPI research papers. MDPI is the number one OA publisher in Korea.


Sungkyunkwan University Joins MDPI’s Institutional Open Access Program

In addition, MDPI announced that Sungkyunkwan University joined MDPI’s Institutional Open Access Program (IOAP). This program offers free access to MDPI online submission system for the institutions and APC discounts to affiliated authors. Thirteen major Korean universities, including Sungkyunkwan University, Kyung Hee University, Chung-Ang University and Catholic University of Korea, have adopted IOAP in Korea.

OA aims to break down barriers that have traditionally restricted access to science, ensuring that knowledge is available to all, regardless of financial situation or institutional affiliations. Authors, academia, and scientific communities are rapidly moving toward OA. MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020.


MDPI CEO Visits Seoul, Korea

In March, Stefan Tochev, Chief Executive Officer (CEO) of MDPI, visited Korea and met with various stakeholders including government agencies, research and academic institutions, universities. During his visit, Stefan highlighted that MDPI continues to pave the way for a world where science is accessible to all, supporting a global community of inclusive innovation and collaborative solutions.

Stefan expressed excitement about the new venture, stating, "Today marks a significant milestone for MDPI as we celebrate the opening of our new office in Seoul, Korea. This expansion is more than just an increase in our physical footprint, it is a pivotal step in our ongoing commitment to making scientific knowledge more accessible, participatory, and inclusive across the globe."

Claude Seo, reflecting on his new role, commented, "I am delighted to have been offered this position of trust within MDPI, the no. 1 scholarly OA publisher. As we establish our presence in Korea, we are dedicated to integrating into the local community and contributing to its vibrant culture. Our commitment goes beyond business growth; it is about creating a more informed and innovative society by embracing and promoting diversity within the scientific community.”

For further inquiries, please contact our Seoul office directly.


About MDPI

A pioneer in scholarly, open access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to open science by making more research free and accessible to everyone. Over 3.3 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of 6000 diligent, well-trained staff members, and an in-house article submission platform that was designed to ensure efficient processes within its 430 fully OA titles.

15 April 2024
Meet Us at the 12th World Biomaterials Congress (WBC 2024), 26–31 May 2024, Daegu, Korea


MDPI will attend the 12th World Biomaterials Congress (WBC 2024) as an exhibitor. We invite researchers from different backgrounds to visit and share their latest ideas with us.

The WBC is a large-scale academic conference supported by the IUSBSE, a global association in the field of biomaterials. The 12th World Biomaterials Congress will attract more than 4,000 participants from all over the world. Participating experts can gather and share the latest information and knowledge in the diverse areas within biomaterials research.

The following MDPI journals will be represented at the conference:

If you are planning to attend the above conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following website: https://www.wbc2024.com/.

7 April 2024
Meet Us at the 28th International Conference on Miniaturized Systems for Chemistry and Life Sciences—Micro-Total Analysis Systems (µTAS 2024), 13–17 October 2024, Montréal, Canada


MDPI will be attending the 28th International Conference on Miniaturized Systems for Chemistry and Life Sciences—Micro-Total Analysis Systems (µTAS 2024) held in Montréal, Canada, from 13 to 17 October 2024.

The µTAS International Conference series is the premier forum for reporting research results in microfluidics, lab-on-a-chip, organ-on-a-chip, wearables, BioMEMS, microfabrication, 3D printing, nanotechnology, integration, materials and surfaces, analysis and synthesis, and detection technologies for chemistry, life sciences, and biomedicine. µTAS 2024 will feature plenary and keynote talks from world luminaries and will offer an opportunity for students and scientists to deliver oral and poster presentations selected from submitted abstracts to a global audience of experts in their area. µTAS 2024 will also include networking and social session for students, minorities, young faculty, and an array of industry exhibitions and presentations, as well as a wonderful cultural experience in Montréal.

During this conference, MDPI will welcome researchers from different backgrounds to visit and share their latest views and research with us.

The following MDPI journals will be represented:

If you plan on attending this conference, feel free to stop by our booth at #50. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please see the following link: https://microtas2024.org/.

2 April 2024
MDPI Insights: The CEO's Letter #10 - South Korea, IWD, U2A, Japan

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts


Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Stefan Tochev (CEO, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), during media meetings at Prain Agency office in Seoul, South Korea.

Visit to Seoul, South Korea

During my recent visit to South Korea, I had the privilege of meeting various stakeholders, including representatives of government, research institutions, and academia, to understand their needs and communicate MDPI’s commitment to accessible science. Accompanied by my colleagues Dr. Giulia Stefenelli and Dr. Jisuk Kang, I engaged with the Korean scientific community, which is increasingly embracing open access (OA).

As the leading OA publisher in South Korea, MDPI is trusted by local authors and in 2023 enjoyed an approximately 30% share of the OA market. South Korea ranks sixth globally for MDPI in terms of research papers submitted and published.

MDPI and South Korea by Numbers

As at 30 March, over 76,000 MDPI articles have been authored by individuals affiliated with Korean institutions. We have over 1,800 active editorial board members (EBMs) from South Korea, with more than 880 EBMs having an H-index between 26 and 50, including 10 serving as Chief Editors.

“South Korea is the sixth-largest contributor to our total publications”

Over the past five years (2019–2023), nearly 120,000 authors affiliated with South Korean institutes have published with MDPI. Specifically in 2023, we received approximately 25,000 submissions from South Korean authors, publishing close to 13,000 articles, resulting in a rejection rate of 47.4%, which is not far below MDPI’s overall rejection rate of 56.4% in 2023.

Institutional Partnerships with South Korea

I am pleased to share that MDPI has more than 825 institutional partnerships worldwide, with 12 in South Korea, including Kyunghee University, Chung-Ang University, and Inha University, among others.


Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), and Stefan Tochev (CEO, MDPI) fielding media questions at Prain PR Agency office in Seoul, South Korea.

Over the past three years (2021–2023), we have had some of the most prestigious academic universities ranked among the top 10 Korean institutions publishing with MDPI. Seoul National University had the highest number of publications with MDPI during those three years, publishing nearly 6,000 papers. Universities such as Korea University and Yonsei University also rank among the top 10 Korean institutions publishing with MDPI.

MDPI Hosts Seminar for Academia and Media

As the world’s leading OA publisher, MDPI is actively democratizing science. This is reflected in the seminars we hosted on 21 March to address questions about our editorial processes and ethical standards. The visit garnered media coverage, reflecting our mission to providing high-quality services and fostering open dialogue in the community.

“MDPI is actively democratizing science”

MDPI in the News


Stefan Tochev (CEO, MDPI) leading a seminar on OA and MDPI at Prain PR Agency office in Seoul, South Korea.

Media coverage generated by our visit to Seoul included the following stories:

“Open access is an unstoppable trend…it will lead the development of the knowledge ecosystem.”

“Papers that the public needs, anyone can use quickly… low-quality publishing is a misunderstanding.”

I greatly appreciate the contributions of everyone who took the time to meet with us, share their stories, and hold us accountable for continuing to provide high-quality publishing services while identifying areas for improvement. I am also excited to announce that we have opened an MDPI office in Seoul and will release a press release on MDPI.com, with details, by the end April 2024. The purpose of the office is to establish a local presence to connect with and support the South Korean academic community through institutional partnerships, conferences, author workshops, stakeholder communications, and more.

Impactful Research

Featured Articles on Women’s Leadership and Healthcare

In celebration of International Women’s Day (8 March 2024), MDPI curated a collection of research articles on various topics, including women’s leadership, reproductive health, preventive healthcare, and a selection of articles from our journal Women.

Women’s Leadership

Women’s Reproductive Health

Women’s Preventive Healthcare

Featured Articles in MDPI Journal Women

Below are a few articles from Women, our journal focused on women’s health, the social determinants of health, and the healthcare system that serves women. The aim of Women is to encourage academics to publish their experimental and theoretical results in detail, to aid reproducibility, and in an engaging style, to aid comprehensibility.

Inside MDPI

 

Championing Women’s Healthcare and Access to Healthcare Information

MDPI colleagues from our offices joined in celebrating #IWD2024. In doing so, we emphasized key missions that encompass:

  • Empowering women to assume leadership and decision-making roles in both business and science.
  • Helping women and girls make informed decisions about their health.
  • Recruiting and developing female talent and fostering inclusive workplace environments.

“We are thrilled to recognize the accomplishments of women scientists”

I am proud to see our colleagues enthusiastically supporting the International Women’s Day call to ‘Inspire Inclusion!’ The heart-hands in the collage below symbolize our appreciation of the achievements of women researchers and the recognition of the trailblazers who have courageously made a mark on societies past and present.

We are thrilled to recognize the accomplishments of women scientists through our many MDPI awards and by highlighting success stories. As inspirational figures, female scientists are paving the way for the next generation of women aspiring to pursue careers in engineering, life sciences, computing, and various other STEM fields.

“I consider myself lucky because I work with incredibly talented women who inspire me every day.”
– Dr. Alessandra Pasut, Winner of MDPI's ‘Biology 2023 Young Investigator Award’

“It’s really important to find a supportive and enabling environment in which to do your science; it would have a big impact on you as a person and on your scientific outputs.”
– Dr. Rhea Longley, Winner of the ‘Pathogens 2023 Young Investigator Award’

Open-access publishing, in particular, allows early-career women researchers to share their work more widely, potentially attracting mentorship opportunities and collaborations. This support is crucial for career development and advancement.

Coming Together for Science

MDPI Joins United2Act in Collective Fight to Stop Paper Mills

In my February 2024 CEO Letter, I highlighted some of our recent initiatives aimed at bolstering our commitment to research integrity, including joining the STM Integrity Hub and expanding our Research Integrity and Publication Ethics team (RIPE). Continuing our efforts in coming together for science, I am pleased to share our participation in the United2Act initiative.

The text below is taken from our official announcement:

United2Act represents an international group of stakeholders in the publishing industry committed to addressing the collective challenge posed to research integrity by paper mills.

Scientists and academic publishers have increasingly noted the alarming proliferation of paper mills, recognized as fraudulent entities seeking to manipulate the publication process for financial profit. These entities engage in fraudulent practices such as falsifying or fabricating data, selling co-authorship of fake papers, manipulating peer review, and including inappropriate citations. These actions pose a significant threat to the integrity of the scholarly record, prompting widespread concern among those involved in the academic community.

MDPI has been actively contributing to combat the undermining of the scientific record. Our editors employ a set of tools to detect potential ethical breaches within a manuscript and to tackle the issue of fake papers.

United2Act’s consensus statement is the outcome of a virtual summit held in May 2023. It involved the participation of research bodies, publishers, researchers/sleuths, universities, and publishing infrastructure from 15 countries and resulted in a Consensus Statement outlining five key areas of action for all stakeholders:

  • Education and awareness
  • Improve post-publication corrections
  • Facilitate and organise research on paper mills
  • Enable the development of trust markers
  • Facilitate dialogue between stakeholders

MDPI is committed to promoting transparency and integrity in scholarly publishing and is continuing to work closely with the scientific community toward this goal.

Closing Thoughts


Left to right: Ryo Hirayama (Marketing Specialist, MDPI), Takashi Sasabe (Marketing Specialist, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Stefan Tochev (CEO, MDPI), at MDPI’s office in Tokyo, Japan.

Visit to Tokyo and Kyoto, Japan

In March, I had the opportunity to visit our Tokyo office and engage with stakeholders in Tokyo and Kyoto. During the visit, I also recorded a video message to welcome Japanese scholars working with MDPI and to highlight our operations in Japan.

We held meetings with Editors-in-Chief, librarians, scholars, and external consultants to gather feedback on our efforts to enhance our reputation and explore additional steps we can take in that direction. Japan's rich cultural heritage, characterized by tradition, respect, and formality, provided valuable insights into meeting the publishing needs specific to Japan.

Japan’s Open Access statistics

Over the years, we have seen a shift from subscription-only to gold OA publishing in Japan, despite the lack of an official mandate. Here are some statistics:

  • 2012: 68% of articles were subscription-only, 6% were green Open Access, and 8% were gold Open Access.
  • 2016: 55% of articles were subscription-only, 6% were green Open Access, and 20% were gold Open Access.
  • 2022: 43% of articles were subscription-only, 7% were green Open Access, and 39% were gold Open Access.

To learn more about the history of OA in Japan as well as about future trends, please read this blog post.

“Japan is the ninth-largest contributor to our total publications”


Left to right: Stefan Tochev (CEO, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI) visiting Kyoto University in Kyoto, Japan.

MDPI and Japan by Numbers

As at 1 April, over 50,000 MDPI articles have been authored by scholars affiliated with Japanese institutions, making the country the ninth-largest contributor to our total publications. Over the past three years (2020–2023), nearly 90,000 authors affiliated with Japanese institutes have published with MDPI, and we have collaborated with over 4,600 Guest Editors from Japan.

In 2023, we published over 8,200 papers from authors associated with Japanese institutions. MDPI collaborates with 41 institutional partnerships in Japan, including the University of Tokyo, Hokkaido University, and Nagoya University. We have over 2,100 active EBMs from Japan, more than 1,050 EBMs having an H-index between 26 and 50, including 13 serving as Editors-in-Chief.

General Feedback – a side note

A general takeaway from our discussions with stakeholders from around the world is that negative perceptions of MDPI often stem from misinformation, misconceptions, or misunderstandings about MDPI and our practices. While we acknowledge our mistakes and work diligently to address them, maintaining a strong editorial procedure and robust peer-review process, I find that educating stakeholders about our how we do what we do and our ongoing improvements tends to help shift opinions.

That said, we recognize the importance of addressing individual concerns. We take feedback seriously and are continuously working to get better while not compromising the core principles that millions of authors appreciate about MDPI.

Stefan Tochev
Chief Executive Officer
MDPI AG

15 March 2024
Interview with Dr. Dora Allegra Carbone, Author of a Highly Viewed Article of Bioengineering

Dr. Dora Allegra Carbone is one of the authors of the highly viewed article entitled “Potential of Porous Substrate Bioreactors for Removal of Pollutants from Wastewater Using Microalgae”, published in Bioengineering (ISSN: 2306-5354).

Dr. Dora Allegra Carbone completed her Ph.D. at the University of Federico II, Italy, in 2017, specializing in microalgal biotechnologies. During her doctoral research, she concentrated on optimizing growth systems for biomass production. This involved comparing traditional liquid bioreactors with newer solid-state systems, including the notable Twin-layer system, which she studied while conducting research at the University of Cologne, Germany. In 2018, she expanded her studies on microalgae and their growth, focusing further on immobilized systems, once again examining the Twin-layer system, also at the University of Cologne. After returning to Italy in 2019, she continued her work in algology across various areas, such as co-cultivating different organisms and treating wastewater at different institutions until 2021. Since then, she has dedicated herself to teaching and scientific outreach. 

The following is an interview with Dr. Dora Allegra Carbone:

1. Could you please briefly introduce the main research content of the published paper?
The paper talks about a new technology, the Porous Substrate Bioreactors (PSBRs), which allows microalgae growth on an immobilized system and solves some problems linked to standard suspended cultivation. This technology seems to bring interesting results in wastewater treatment. This paper is the result obtained by PSBRs in this field.

2. Could you describe the difficulties and breakthrough innovations encountered in this research?
PSBRs represent an innovative technology demonstrating promising outcomes across various facets of microalgae cultivation, such as astaxanthin production. These systems have exhibited several advantages in wastewater treatment compared to classic suspended cultivation methods, including enhanced cost-effectiveness, reduced water consumption, and elevated levels of biomass productivity. Therefore, they present themselves as compelling alternatives to traditional methods in rural areas and small-scale decentralized systems within urban settings, such as hospitals. Nonetheless, a significant challenge lies in adopting these systems for large-scale applications. The scaling-up process necessitates a sustainable operation, incorporating automated algal biomass harvesting. Hence, future research should prioritize addressing these obstacles to facilitate the successful integration and utilization of PSBR technology in wastewater treatment and other biotechnology fields.

3. What made you decide to publish a bioengineering article? Why did you choose Bioengineering?
I have had previous publications with MDPI, and I have always found them to be reliable. Throughout my career, I have considered MDPI to be a top-notch publisher for research. Additionally, I have come across several bioengineering papers published by them, and they consistently exhibit high quality and are quite interesting as well. The Bioengineering journal produces valuable work which makes them trustworthy, and I would not hesitate to recommend them.

4. What was your experience publishing with Bioengineering?
My experience with this journal has been exceptional. The editorial team is truly efficient. They consistently respond promptly to my inquiries and provide helpful support whenever needed. Moreover, I have found that the time it takes for my work to be published is remarkably fast, which has been incredibly beneficial for my work.

5. How do you think open access impacts authors?
Open access increases the visibility of scientific papers without barriers; consequently, the number of citations and the impact factor significantly increase. As a result, this process amplifies the recognition of research and offers greater opportunities for young scientists to succeed in their respective fields.

6. What do you hope that readers will get from your paper?
I sincerely hope the readers recognize the PSBRS system's immense potential in wastewater treatment. Certainly, with further in-depth studies and ongoing research, this technology can significantly enhance wastewater treatment processes on both small and large scales. It promises substantial improvements in efficiency, effectiveness, and environmental sustainability. Embracing and advancing the development of PSBRS technology could prove instrumental in addressing pressing challenges in wastewater management, benefiting communities and ecosystems alike.

4 March 2024
MDPI Insights: The CEO's Letter #9 - Romania, Research Integrity, Viruses

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts


Reka Kovacs (Deputy Office Manager, MDPI), Stefan Tochev (CEO, MDPI), and Sandra Ana Spatariu (Office Manager, MDPI) at the MDPI office in Cluj, Romania.

MDPI’s Impact on Romania

In February, I visited our office in Cluj, Romania. I worked closely with our senior office managers and various teams, including the departments of training, marketing and conferences, as well as our journal relationship specialists, reviewing our service to the local scholarly community. During the visit, I also met with representatives from Babes-Bolyai University and the Technical University of Cluj-Napoca. Our multifunctional Romanian office plays an important role in supporting our collaborations with the local market as well as helping to meet MDPI’s overall business needs.


Feedback and strategy meeting with a group of MDPI’s Journal Relationship Specialists at the MDPI office in Cluj, Romania.

With 22,436 articles, Romania ranks as a top 20 contributing country to MDPI’s total number of papers published as at 28 February 2024. This highlights the importance of our collaboration with Romanian-affiliated authors and the growing opportunity to support their publishing needs. MDPI is one of the few academic publishers with a significant presence in Romania, boasting over 360 colleagues across our offices in Bucharest and Cluj. We are also proud to hire colleagues from local institutions to launch their careers within publishing.

Romania ranks as a top 20 contributing country.

The Numbers: 2019–2023

MDPI has seen a healthy increase in submissions from Romanian authors over the past three years, from 8,439 in 2021 to 11,866 by end of 2023, with most submissions going to journals such as Sustainability, Medicina, Diagnostics, IJMS, Applied Sciences, and JCM. From 2019 to 2023, MDPI published articles from 32,145 authors affiliated with Romanian institutions. Over those years, we have worked with Romanian Guest Editors on nearly 3,000 occasions to support their Special Issue and Topical collections.

With more than 300 Editorial Board Members from Romania, 34 appear on the board of Mathematics, 27 on Materials, 19 on Polymers, 18 on Coatings, and 16 on Molecules, while three serve as Section Editors-in-Chief (SEiC) on our journals Coatings (3.4 IF, 4.6 Citescore), Magnetochemistry (2.7 IF, 3.5 Citescore), and Chemosensors (4.2 IF, 3.9 Citescore).

Institutional Open Access Programs

Our commitment to working with institutions is evident in Romania, where we have established eight Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Bucharest, the University of Medicine and Pharmacy Cluj-Napoca, and most recently the National Institute for Laser, Plasma and Radiation Physics.

Our growth and presence in Romania are a true testament.

We also have IOAP agreements with Babes-Bolyai University and the Technical University of Cluj-Napoca, where I had the opportunity to meet senior stakeholders during my visit. Below are a few photos capturing our meeting with Prof. Radu Silaghi-Dumitrescu (Head of Faculty of Chemistry, Babes-Bolyai University) at the MDPI office in Cluj, Romania, along with a photo from our meeting with Vice Deans Nicoleta Cobarzan, Nicoleta Ilies, and Hoda Gavril, from the faculty of Civil Engineering at the Technical University of Cluj, Romania.


Our growth and presence in Romania are a true testament to the service we provide to the scholarly community and the relationships we foster in that region. We look forward to continuing to support Romanian scholars and institutions by providing a valuable and trusted experience with MDPI, the leader in open access publishing.

Impactful Research

MDPI Joins the STM Integrity Hub

MDPI has long been a supporter and partner of STM, with our involvement ranging from sponsoring and attending events to helping organize event programs. By joining the STM Integrity Hub, we aim to further our commitment to STM initiatives aimed at safeguarding the integrity of science.

“We are pleased to welcome MDPI as the 35th organisation participating in the Hub. This expansion is critical, as every new member enhances our capacity to prevent fraudulent submissions from entering the academic record.”

Joris van Rossum, Director of Research Integrity, STM

MDPI operates in full alignment with STM Integrity Hub's values of shared data and experiences. We strongly believe in collaboration and open exchange for the purposes of creating a holistic approach to support research integrity at MDPI itself and across the entire academic publishing industry. The Integrity Hub is an excellent example of how publishers can come together to jointly address industry-wide challenges related to research integrity, such as manuscripts that breach research integrity standards and paper-mills.

I look forward to our Research Integrity and Publication Ethics Team (RIPE) team immersing themselves in this initiative, exchanging information, best practices, and tools for the benefit of the entire scholarly ecosystem. We believe that ethical publishing standards should be implemented across the board, and we aim to be rigorous in our approach, addressing research integrity issues and improving the impact of published research.

Inside MDPI

MDPI Expands Research Integrity and Publication Ethics Team (RIPE)

In addition to external collaborations and joint initiatives aimed at further strengthening our commitment to research integrity, we are also enhancing our internal efforts. This includes improving our processes and guidelines and expanding our teams and departments to ensure quality assurance throughout our publishing process.

We are pleased to announce the expansion of our Research Integrity and Publication Ethics Team (RIPE) at MDPI. The RIPE team has recently welcomed new colleagues, each bringing unique skills and a personal commitment to prioritize ethical considerations in all our work.

The demand for research integrity and high ethical standards in academic publishing is steadily rising across our industry. Our expanded RIPE team will work to enhance and align our practices with industry best practices, ensuring excellence in research integrity and publication ethics.


Stefan Tochev (CEO, MDPI) introduces Dr. Tim Tait-Jamieson (Research Integrity Lead, MDPI) for his presentation on MDPI’s Retraction and Approval Process to a group of Journal Relationship Specialists at the MDPI office in Cluj, Romania: “The demand for research integrity and publication ethics is steadily rising across our industry.”

Introducing our Research Integrity and Publication Ethics Team

Led by Dr. Tim Tait-Jamieson (Research Integrity Lead), the RIPE team comprises Dr. Ivana Resanovic (Research Integrity Manager), Dr. Lavinia Rogojina (Research Integrity Manager), Ms. Diana Apodaritei (Research Integrity Specialist), Dr. Zoltan Mihaly (Research Integrity Specialist), Mr. Aleksandar Đukić (Research Integrity Specialist), Ms. Ana Stankovic (Research Integrity Specialist), and Ms. Anna Pena (Publication Ethics Assistant).

Please click here to access everything that you need to know about MDPI’s Research and Publication Ethics.

With this span of complementary roles, the RIPE team collaborates directly with journal editorial teams and works closely with various departments, including our Scientific Office Board and our Journal Relationship Specialists. The team’s primary objectives are to help prevent issues regarding research integrity and publication ethics during peer review, uphold MDPI’s ethics policies, adhere to industry standards, and resolve publication ethics and research integrity issues and complaints.

Quality Updates to Special Issues Oversight

At MDPI, we are committed to reviewing policies pertaining to the quality of research. In this blog post, Shaheena Patel (Communications Associate, MDPI), outlines two recent updates to MDPI journal processes. These updates pertain to Special Issue (SI) quality guidelines, in line with criteria provided by COPE and DOAJ. Alongside the SI updates, details regarding the new minor corrections policy introduced in 2024 are provided in the blog.

The two updates we implemented include greater oversight and the verification of Guest Editor credentials. These guidelines require that Editors-in-Chief (EiCs) and Editorial Board Members (EBMs) take responsibility for overseeing SIs.

PS. Thank you, James Butcher, for featuring this up in your 67th issue of the Journalogy newsletter.

Read more:

Coming Together for Science

Viruses 2024 – A World of Viruses

I am pleased to share the success of our MDPI conference Viruses 2024 – A World of Viruses, held 14-16 February, in Barcelona. With 240 registrations, this event brought together top scientists, researchers, and industry experts from 40 countries to share their findings on the latest developments in viral pathogenesis and immune responses.

Attendees gathered for the 5th edition of the Viruses’ conference, where we hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes, along with 14 invited speakers, 47 selected speakers, and nine flash poster presenters, to discuss the most significant issues in virology today.

Recap on the #Viruses2024 Conference

Take a look at the key moments from MDPI’s Viruses event and please join us in commemorating a gathering for global knowledge and cooperation. A heartfelt thank-you to all attendees; their passion and engagement played a crucial role in making this event an engaging success!

Below are calls to action from the keynote speakers encouraging collaboration and communication:

“There’s never been a better time than now to really take the power that we have both in terms of basic research and also in biotech and pharma to develop antiviral agents.” - Dr. Charles M. Rice, The Rockefeller University, New York, USA

“The collaboration between labs is absolutely essential. Improving initial detection and improving communication is a must for all of us working in science.” - Prof. Dr. Luis Enjuanes, National Center of Biotechnology (CNB-CSIC), Madrid, Spain

Our thanks go to our sponsors and partnering societies, our Viruses journal and editorial team, our Barcelona colleagues, and the social media, conference and other MDPI teams for making this event a memorable occasion. View the event gallery here.

Upcoming In-Person Event

24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities
Location: Barcelona, Spain

Esteemed speakers at MMCS 2024 include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.

Find more upcoming MDPI events here.


Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

Researcher to Reader (R2R) Conference

From 20–21 February 2024, I had the pleasure of attending the Researcher to Reader (R2R) conference in London, which MDPI has proudly sponsored over the years. The conference programme offered a variety of session formats, including workshops, panel discussions, debates, interviews, presentations, and lightning talks, with opportunities to discuss relevant topics.

We take pride in supporting the scientific community, bringing researchers across the world together to network, exchange ideas and share the latest in science and publishing. In 2023, MDPI invested close to 2 million CHF in sponsoring over 2,000 scientific and publishing-related conferences worldwide.

R2R Peer Review Innovations Workshop

I found the R2R conference to be engaging, with the workshops being particularly enjoyable. My colleague Giulia Stefenelli (Chair of Scientific Office Board) and I participated in the “Peer Review Innovations” workshop, which spanned four sessions over the two days. These sessions explored the future of peer review and how we can improve the peer review process for everyone involved. Notably, the large majority of attendees expressed their opinion that peer review, as currently practiced, requires significant improvement. Together, we collaborated on potential immediate and long-term improvements and innovative processes, aiming to create an ecosystem beneficial to all stakeholders by strengthening submission systems with the aim of reducing threats and making authors more responsible for their work. We also discussed the opportunity for academic institutions to better scrutinize the quality of the work produced and submitted to journals.

Our group comprised publishers, software providers, librarians, and more, bringing diverse perspectives to the discussions. These interactions were relevant to MDPI’s ongoing conversations, providing insights to our efforts. The session also made me appreciate that MDPI is doing well, as the group discussions included the subject of various quality checks that we have already embedded in our processes, ensuring that we keep abreast of industry standards.

The need for an optimized system to incentivize the activities of editors and reviewers was also a focus of discussion, as well as the support that reviewers need from publishers via the provision of strong reports through fixed forms, questionnaires and training.

At MDPI, we are currently auditing our reviewer program to improve reviewer recognition, guidelines, and methods for identifying suitable reviewers, while maintaining our commitment to quality and timeliness.

Congratulations to Mark Carden, Conference Director, and the R2R team for organizing a productive and successful event. PS: The break times were greatly appreciated as well!

Stefan Tochev
Chief Executive Officer
MDPI AG

31 January 2024
MDPI Insights: The CEO's Letter #8 - Altmetric and Flat Fee Agreement

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI and Digital Science Meeting

At MDPI, we are committed to providing our authors with the essential tools to publish, promote, and track their research. In line with this commitment, we have established a longstanding collaboration with Digital Science, a company specializing in research data and analytical insights for the research community. Our collaboration integrates their Altmetric tool, offering us and our authors the ability to track a variety of sources that monitor and report attention surrounding publications.

As part of our collaboration, we recently hosted Cathy Holland, Director of Global Publisher Business Development, and Helen Cooke, Managing Director of Publisher Sales, from Digital Science, at our MDPI headquarters in Basel, Switzerland.


Left to right: Facundo Santomé (Senior Marketing Manager, MDPI), Constanze Shelhorn (Indexing Manager, MDPI), Cathy Holland (Director of Global Publisher Business Development, Digital Science), Helen Cooke (Managing Director of Publisher Sales, Digital Science), and Stefan Tochev (CEO, MDPI) in front of MDPI headquarters in Basel, Switzerland.

During our meeting, we discussed MDPI’s publishing philosophy and explored further avenues for collaboration. We look forward to continuing our partnership with Digital Science, aiming to improve our services yet further and meet the needs of our authors more closely than ever.

What is Altmetric?

You will notice that MDPI articles feature an Altmetric score, a colourful doughnut capturing the score in the upper right corner of the article page. This score represents ‘alternative metrics,’ as distinct from traditional metrics such as Impact Factor, CiteScore, and Scimago Journal Rank.

Altmetrics complement traditional citation-based metrics by capturing online discussions related to a specific research topic. By analyzing both sets of data, we can obtain a comprehensive understanding of the attention a particular research output receives and the sources in which it is mentioned.

“Almetric provides visual insights into where research is being discussed”

Sources Tracked by Altmetric


Altmetric badge showing the Altmetric score and colour-coded mention sources.

Altmetric monitors various sources, categorizing them into segments such as policy documents, peer reviews, Wikipedia, news and blogs, and social media, among other sources. Each category is identifiable by a specific colour.

The Altmetric badge provides visual insights into where the research is being discussed. A more colourful badge indicates broader mentions across multiple platforms. Such tracking enables us to gauge the extent of an article’s online dissemination, noting that increased visibility may correlate with higher citation rates.

Read more:

Impactful Research

Ten High-Altmetric Articles Published by MDPI

As at 30 January 2024, Altmetric has tracked 670,500 MDPI research outputs from MDPI, resulting in over 4.3 million mentions. This includes over 71,894 mentions in policy and patents and 294,714 mentions in news and blogs, with some achieving an Altmetric score as high as 28,754.

So, what is a good Altmetric score? There are various ways to put this score into context. You can find out more about the score in context and how to evaluate your work by this means.

Here are ten MDPI papers ranking in the top 5% of all research outputs scored by Altmetric.

“Accuracy in Wrist-Worn, Sensor-Based Measurements of Heart Rate and Energy Expenditure in a Diverse Cohort”

J. Pers. Med. 2017, 7(2), 3; https://doi.org/10.3390/jpm7020003

Altmetric page: https://mdpi.altmetric.com/details/20477344

Altmetric shows that this article appeared in 253 news stories from 209 outlets including Forbes, BBC, and Fox News.

“Daylight Saving Time and Acute Myocardial Infarction: A Meta-Analysis”

J. Clin. Med. 2019, 8(3), 404; https://doi.org/10.3390/jcm8030404

Altmetric page: https://mdpi.altmetric.com/details/57654628

Altmetric shows that this article appeared in 295 news stories from 207 outlets including Forbes, The Atlantic, and New York Times.

“The Preliminary Analysis of Cave Lion Cubs Panthera spelaea (Goldfuss, 1810) from the Permafrost of Siberia”

Quaternary 2021, 4(3), 24; https://doi.org/10.3390/quat4030024

Altmetric page: https://mdpi.altmetric.com/details/111086701

Altmetric shows that this article appeared in 182 news stories from 134 outlets including CBC News, CNN, and National Geographic.

“Not the Cat’s Meow? The Impact of Posing with Cats on Female Perceptions of Male Dateability”

Animals 2020, 10(6), 1007; https://doi.org/10.3390/ani10061007

Altmetric page: https://mdpi.altmetric.com/details/83796184

Altmetric shows that this article appeared in 124 news stories from 98 outlets including VICE, CNN and The Guardian.

“Behaviour and Welfare Impacts of Releasing Elephants from Overnight Tethers: A Zimbabwean Case Study”

Animals 2022, 12(15), 1933; https://doi.org/10.3390/ani12151933

Altmetric page: https://mdpi.altmetric.com/details/133463915

Altmetric shows that this article appeared in 192 news stories from 186 outlets.

How do I use altmetrics?

Altmetric Explorer provides a detailed step-by-step guide and instruction video for first-time users of the tool. The guide includes useful diagrams that make it easy to get started.

Sharing Research Online

For research to be tracked across different sources, Altmetric needs a research output with a persistent identifier: a DOI, ISBN, PubMed ID, handle ID, etc. When sharing research, it is important to include a link to the original research output.

“An Update on Eukaryotic Viruses Revived from Ancient Permafrost”

Viruses 2023, 15(2), 564; https://doi.org/10.3390/v15020564

Altmetric page: https://mdpi.altmetric.com/details/142929875

Altmetric shows that this article appeared in 250 news stories from 180 outlets including CTV, Fox News, and CNN.

“The Global Problem of Insufficient Sleep and Its Serious Public Health Implications”

Healthcare 2019, 7(1), 1; https://doi.org/10.3390/healthcare7010001

Altmetric page: https://mdpi.altmetric.com/details/53406248

Altmetric shows that this article appeared in 252 news stories from 168 outlets including BBC, Harvard Business Review, and Forbes.

“A Detailed Review Study on Potential Effects of Microplastics and Additives of Concern on Human Health”

Int. J. Environ. Res. Public Health 2020, 17(4), 1212; https://doi.org/10.3390/ijerph17041212

Altmetric page: https://mdpi.altmetric.com/details/86529137

Altmetric shows that this article appeared in 197 news stories from 150 outlets including BBC, The Tribune, and World Economic Forum.

“An Empirical Study of Chronic Diseases in the United States: A Visual Analytics Approach to Public Health”

Int. J. Environ. Res. Public Health 2018, 15(3), 431; https://doi.org/10.3390/ijerph15030431

Altmetric page: https://mdpi.altmetric.com/details/34714141

Altmetric shows that this article appeared in 232 news stories from 149 outlets including Forbes, New York Times, and Harvard Business Review.

“Garden Scraps: Agonistic Interactions between Hedgehogs and Sympatric Mammals in Urban Gardens”

Animals 2023, 13(4), 590; https://doi.org/10.3390/ani13040590

Altmetric page: https://mdpi.altmetric.com/details/142934305

Altmetric shows that this article appeared in 172 news stories from 168 outlets including BBC.

Inside MDPI

MDPI Annual Meeting Celebrations in China

On Thursday 25 January, over 1,300 MDPI colleagues from our two offices in Beijing gathered to kick off MDPI’s traditional ‘Annual Meetings.’ These celebrations take place in MDPI’s offices across China, including Dalian, Tianjin, Wuhan, and Nanjing.

The evenings include performances, informative talks and presentations, awards, and entertainment, providing an ideal platform to recognize our colleagues, celebrate their achievements, and set our sights on the future.

“It is essential that we stay connected and share best practices”

I sent a video congratulating everyone on their work and sharing our vision of building MDPI into the most trusted OA publisher, highlighting the roles each of us has to play in achieving that goal.

Unfortunately I could not join in person, but you may recall my recent trip, when I visited our offices in Beijing and Wuhan, which I look forward to visiting again this year.

Although our headquarters are in Basel, Switzerland, and we are expanding throughout Europe and North America, the majority of MDPI’s workforce is in China and throughout the Asia-Pacific region, including offices in Singapore, Thailand, Japan, and newly opened office in South Korea. It is essential that as a global organization, we stay connected and share best practices in order to grow collectively and continue providing the exceptional service to our authors.

The Annual Meeting is a moment to reflect and enjoy the year’s hard work and dedication.

I extend our best wishes to all for the Chinese New Year (Xīnnián kuàilè)!

Coming Together for Science

MDPI and TU Delft Adopt Flat Fee Model in Extended Partnership

We are excited to announce a renewed three-year partnership with Delft University of Technology (TU Delft) in the Netherlands. This collaboration introduces a fixed lump-sum fee, covering publishing costs from 2024 to 2026.

“This initiative reflects our dedication to transparent and inclusive publishing”

TU Delft-affiliated authors will enjoy cost-free publishing in any MDPI journal during this period, aligning with our commitment to removing barriers for open access publishing. The agreement supports Plan S compliance and facilitates a seamless publishing process for TU Delft corresponding authors. This initiative reflects our dedication to transparent and inclusive publishing, providing stability and predictability both for authors and for institutions.

For further details on our Institutional Open Access Program (IOAP), please contact us.

Benefits to MDPI’s IOAP

At MDPI we have a long tradition of partnerships, including our Institutional Open Access Program (IOAP). IOAP supports institutions through simplification, access, transparency, APC discounts, and institutional repository deposits. The program simplifies administrative processes, offers central payment, and allows easy opting in and out. Participants gain free access to Susy, MDPI’s online submission system, with extensive article metadata and exportable data. APC discounts and Book Processing Charge discounts are available for affiliated authors. Automated deposits to institutional repositories and streamlined matching of papers to IOAP participants enhance the overall experience.

For further information, see our IOAP FAQ.

Closing Thoughts

Reflections on the 2024 APE Conference

MDPI was proud to co-sponsor the Academic Publishing in Europe (APE) 2024 Conference that took place in Berlin, Germany, from 9–10 January 2024.

The conference theme, ‘Keep the Conversation Going!’, explored the evolving landscape of scholarly communication. APE is one of the key conferences I make a point to attend each year. January offers a valuable opportunity to engage with new contacts, reconnect with familiar faces, and participate in impactful discussions and presentations among professionals, scholars, and practitioners in the field.

“It's fascinating to see how other publishers are leveraging AI”

Highlights

Some of the standout panels for me include: the role of the UN Sustainable Development Goals (SDGs) within the publishing industry. It was encouraging to hear the current status quo, though I was eager also to learn about the exciting projects planned for 2024 and beyond. These will allow us to track progress in subsequent years. At MDPI, we remain committed to promoting Open–Access (OA) content on SDGs through scientific articles and books. Furthermore, we extend our commitment to sustainability by financially supporting researchers through initiatives such as the World Sustainability Award and the Emerging Sustainability Leader Award, as well as waiving the APC for feature papers on each SDG.

In recent years, discussions on AI have become increasingly prominent at such conferences. It’s fascinating to see how other publishers are leveraging AI to meet the evolving needs of their audiences while at the same time using it to safeguard the scientific process. Other engaging panels that I enjoyed included updates on transformation beyond transformative agreements, the principles of lean change, incentive structures related to research integrity, and the panel on reviewer incentives.

“We can share best practices and lessons learned”

Incorporating MDPI’s Insights into Conferences

I must confess that I sometimes feel overlooked when MDPI is not invited to participate in crucial industry discussions. As the leading open access publisher and the third-largest publisher overall, we possess extensive experience in many of these areas and can offer valuable contributions to these discussions. We can share best practices, lessons learned, and our thinking about future trajectories. For instance, in panels discussing reviewer incentives, at MDPI we offer a discount voucher to reviewers for future submissions, reflecting our commitment to fostering a robust peer review process. In 2022 alone, MDPI collected over 1.4 million peer review reports, informing the decision-making processes of our editors. Given our expertise in these areas, it would be natural to include MDPI in such discussions. I therefore extend an invitation to future conference organizers to consider MDPI for speaking engagements and collaborative opportunities.

Stefan Tochev
Chief Executive Officer
MDPI AG

25 January 2024
Acknowledgment of the Reviewers of Bioengineering in 2023

In recognizing the exceptional efforts of our reviewers in 2023, we express our sincere gratitude for upholding the high standards of Bioengineering. Their commitment ensured the rigorous peer review that is integral to quality academic publishing.

In 2023, Bioengineering received 5766 review reports, from 4227 reviewers. This past year, we worked with reviewers from 87 countries and regions, reflecting the diversity in our collaboration with research communities. Their dedication shapes scholarly discourse and advances global research. The editorial team expresses gratitude for the vital role played by each reviewer in the Bioengineering family throughout 2023, and we look forward to their continued support in 2024.

The following are the reviewers who have consented to show their names:

A. Raja Annamalai Kinga Turzó
Aalap Chokshi Kishore Bingi
Abdelghani Dahou Klaus Peter Latté
Abdolhassan Kazemi Kok Beng Gan
Abdolreza Jamilian Konstantin Kozlov
Abdorreza Mesgar Konstantin Yarygin
Abdul Jatoi Koyeli Girigoswami
Abdullah Amru Indera Luthfi Krishna Kant
Abdulnaser M. Alshoaibi Krisztina Nikovics
Abhishek Jha Kunal Pal
Abraham Pouliakis Kuntal Maity
Abul Doulah Kuosheng Cheng
Adebowale Obalalu Lan Lin
Adel Elamri Lanju Mei
Adel Girgis Laszlo Csirmaz
Adem Ozcelik Lateef Ahmad
Afzal Hussain Laura Bulgariu
Agnishwar Girigoswami Laura Burattini
Agostino Guida Laura Gastaldi
Ahmad Bazli Ramzi Laurent Dewasme
Ahmad Hassanat Leila Allahqoli
Ahmed Abass Leonardo Pagnotta
Ahmed El-Fiqi Leonid Bystrykh
Ahmed El-Shanshory Leslie Pendrill
Ahmed Fatimi Leticia Xochitl López Martínez
Ahsan Sarwar Rana Lev Kazakovtsev
Aike Qiao Lewis Gladius
Ajay Kumar Yagati Li Wang
Ajinkya Pawar Liana Anicai
Akalesh Verma Liangtao Yang
Akira Sakai Lin Zhang
Akmalbek Bobomirzaevich Abdusalomov Lina Vieira
Alaa Adawy Linda Paternò
Alberto Battistel Lioua Kolsi
Alberto Porta Lisandro Lovisolo
Alberto Rodriguez-Archilla Liudmila Gerasimova-Meigal
Aleksander Mendyk Loganathan Rangasamy
Aleš Fidler Lorenzo Faggioni
Alesandr Krasnov Luca Fredianelli
Alessandra Giuliani Luca Redaelli De Zinis
Alessandro Di Rienzo Lucia Barra
Alessio Paladini Lucia Rocco
Alexander Gusev Luciano Bissolotti
Alexander Laemmle Ludovic Tricoire
Alexander Meigal Luigi Perotti
Alexander Moskalensky Luis Coelho
Alexander Netrusov Luis Dias
Alexander Novikov Luis Mariano Esteban
Alexander Panich Lukas Holzer
Alexander Pyatakov Mabel Noemí Brunotto
Alexander S. Machikhin Maciej Zaborowicz
Alexander Shtil Mahdi Roozbeh
Alexandre de Brevern Mahmoud Elbattah
Alexandre Vetcher Mahmoud Tabrizi
Alexandru Lavric Mahmud Iwan Solihin
Alexey Beskopylny Makoto Nakamura
Alexey Ruchay Malaya Nath
Alexey Smolin Małgorzata Chojak
Alfonso Maria Ponsiglione Manel Santafe
Alfred Ankrah Manoj Sharma
Ali Al-juboori Mansi Gandhi
Ali Salehzadeh-Yazdi Manuel Prado-Velasco
Ali Zarrabi Manuel Rodríguez-Ortega
Amar Nath Chatterjee Manuela List
Ami Mehta-Doshi Maqsood Ahmed Siddiqui
Amid Shakeri Marat Leonidovich Rudakov
Amine Khaldi Marc C. A. Stuart
Amir Benzaoui Marcelo Suzuki
Amirmasoud Ahmadi Marcin Kozuch
Amirtharajan Rengarajan Marco Invernizzi
Amit Banerjee Marco Schieppati
Amjad Abu Hasna Marco Zedda
Ammar Saleem Marcos Brioschi
Amr Arafat Marek Pagáč
Amr shehabeldine Marga López
Amritlal Mandal Margaret Saha
Amro Amara Maria A. Bonifacio
Amroune Salah Maria Botelho
Ana Joaquina Perez-Berna Maria D. Rikkou-Kalourkoti
Ana Maria Buzaleh Maria Federica De Riccardis
Ana Rita Caseiro Santos Maria Giovanna Gandolfi
Anatoly Karavaev Maria Giovanna Scioli
André Lopes Maria Jose De Jesus Valle
Andre Luiz Costa Maria Lepore
Andre van Zundert Maria Luiza Mello
Andrea Bagno Maria Pia Cavatorta
Andrea Barucci Maria Pia Ferraz
Andrea Capodaglio Maria-Elissavet (Mariliza) Nikolaidou
Andrea Maria Patelski Marian Simka
Andrea Mastinu Mariana Domnica Stanciu
Andreas G. Tsantes Mariana Ferdes
Andrei Vasile Nastuta Mariana Floria
Andrei Victor Sandu Marija M. Vuksanović
Andrej Savic Marina Carbone
Andres Barajas-Solano Marina Piscopo
Andres-Amador Garcia-Granada Mario Amatria
Andrew J. Mário Vaz
Andrew Kolarik Marioara Avram
Andrey Bogomolov Marisa Varrenti
Andrey Kovalev Markus Neureiter
Andrii Kondratiev Markus Oertel
Andrzej Kasperski Marta Carvalho
Angela De Bonis Martin Meier
Angelo Naselli Martine Pithioux
Anna Kabłak-Ziembicka Marzia Segù
Anna Paradowska-Stolarz Masashi Mizuguchi
Anna Scotto d'Abusco Massimo Corsalini
Anran Ran Massoud Amini
Antonio Di Martino Mati Pääsuke
António Manuel de Amaral Ramos Matteo Bruno Lodi
Antonio Nenna Matthew Bernards
Antreas Kantaros Maximilian Deußing
Anuchit Jitpattanakul Mayur Virarkar
Anurag Satpathy Md Belal Bin Heyat
Anusha Ekanayaka Md Sofiqul Islam
Apostolos Tsolakis Megat Syahirul Amin Megat Ali
Arafa Aly Mehdi Bahrami
Arash Kia Mehdi Mogharabi-Manzari
Arda Isik Mehran Emadi Andani
Arianna Carnevale Meijuan Chen
Arkalgud Ramaprasad Meir Barak
Arnaldo Santos Mengze Xu
Arnulfo Ramos-Jiménez Michael Arkas
Arulselvan Palanisamy Michael Brimacombe
Arup Acharjee Michael Gray
Arvind Negi Michael Liebman
Asmaa Abdella Michael Shestopalov
Ateeq Ur Rehman Michaela Cellina
Athanasios Papadopoulos Michel Roethlisberger
Athina Angelopoulou Michele Boffano
Atkinson Irina Michitaka Yoshimura
Aydi Abdelkarim Mieszko Wieckiewicz
Ayhan Celik Mikhail Kostik
Ayhan Esi Mikhail Ryazantsev
Babak Chehroudi Milan Poudel
Bao Yang Milan Toma
Baolei Guo Milos Kojic
Barbara Jasiewicz Min Dai
Bart Vande Vannet Ming-Der Lin
Bartosz Małkiewicz Mingjian Shi
Basanta Kumar Biswal Mingzhu Sun
Batyrkhan Omarov Miran Kondrič
Bennett Amaechi Mircea Ioan Popa
Beom Sun Chung Mithun Rudrapal
Bernard Hernandez Mizuho Nishio
Bikash Koli Dey Mohamad Shahgholi
Bilal Kirmani Mohamed Abuzaid
Bing Wang Mohamed Ali
Bo Luan Mohamed Jaber
Bogdan Ene-Iordache Mohamed Trabia
Bogdan Gherman Mohammad Ashfaq
Bogdan Istrate Mohammad Etoom
Bogdan Oancea Mohammad Hossein Moattar
Bogdan Socea Mohammad Reza Daliri
Bogdan Tutunaru Mohammad Rezapour
Bogdan Walkowiak Mohammed Abdullah
Bogomir Milojevic Mohammed Emran
Bohan Yin Mohammed H. Alsharif
Bojan Masanovic mohammed hawash
Boris A. Galitsky Mohammed Salman Shazeeb
Boris Dzantiev Mohammed Shuaib
Braden Fleming Mohammed Zakariah
Bruce Milthorpe Monica Betta
Bruno Bonnechère Mónica Martins
Camillo La Mesa Monika Łopuszańska-Dawid
Cândida Malça Monika Papież
Carla Masala Monika Prakash
Carlos A. García-González Morteza Taheri
Carlos Cerdán Santacruz Mostafa Kamal Masud
Carlos F. Geraldes Muahammad Atiq Ur Rehman
Carlos Hall Mubarak Mustapha
Carlos López-de-Celis Muhammad Akram
Carlos Miguel Marto Muhammad Altaf Khan
Carlos Rovere Muhammad Khalis Abdul Karim
Carlos Torres-Torres Muhammad Sardaraz
Carmen Gaidau Muhammad Shafiq
Carmen Hernandez Muhammad Tariq
Carmen Zaharia Muhammed Yildirim
Carson Leung Muhammet Baykara
Catherine Park Mukesh Meena
Cevat Erisken Munho Ryu
Chandra Mishra Murat Koklu
Chang Wei Hsieh Murni Sarian
Chang Won Jeong Mustafa Bayram
Changli Zhao Mustafa Demirci
Changzheng Chen Myles Jones
Chao Wang Nafisa Gull
Chao Zhang Nagavendra Kommineni
Charity Ngoatle Nahum Rosenberg
Cheng Chen Naiying Mao
Cheng Yang Naji Kharouf
Chenzhen Zhang Nan Yang
Cherng-Yuan Lin Narongchai Autsavapromporn
Chetta Massimiliano Natale Musso
Chhavi Sharma Natalia Chumakova
Chiara Martinelli Nathan K. Evanson
Chichun Pan Neelamadhab Padhy
Chih-Kun Hsiao Nejc Umek
Chris Wei Zhou Nektarios Kalyvas
Christian Gernhardt Nenad Ignjatović
Christian Maibohm Neofytos Komninos
Christian Müller Nianfeng Sun
Christie Ying Kei Lung Nicola Armstrong
Christoph Berliner Nicolas Joudiou
Christophe A. Marquette Nicoletta Cera
Christos Papaneophytou Nicos Maglaveras
Christos Rahiotis Nikita Minaev
Cinzia Franchin Nina Anfinogenova
Clare Selden Nir Erdinest
Claudio De Lazzari Nithesh Naik
Colleen M. McDowell Nitish Nayak
Congqiang Zhang Nizar Faisal Alkayem
Constantin Munteanu Noriko Takegahara
Constantinos Koutsojannis Noureddine Issaoui
Cristiana Corsi Nuno Mendes
Cristina Chircov Oleg Shichalin
Cristina Gluhovschi Olexander Barmak
Curtise K. C. Ng Olga Lyublinskaya
Cyrille Blondet Omid Akhavan
Dachang Zhu Omneya Attallah
Dalia Medhat Onur Güler
Dan-Alexandru Szabo Orion Itzhak
Dandan Tu Oscar de Lucio
Daniel Aguado Otávio Augusto Chaves
Daniel Dalla Torre Othmane Merah
Daniel Pozza Panagiotis Mallis
Daniel Torres-Lagares Pankaj Attri
Daniela Opriş-Belinski Paola Manini
Daniele Corbo Paolo Benna
Daniele Panetta Paolo Boffano
Daniele Ugo Tari Paolo Cavoretto
Daniil Bratashov Paolo Spinnato
Danijela Budimir Mršić Paolo Zaffino
Danilo Lofaro Paris Jafari
Danish Javeed Pascal Pineau
Dariusz Mikołajewski Patricia Godoy
Darko Božanić Patrick Martin
Daryoush Shahbazi-Gahrouei Paul Annus
Dave Mangindaan Paul Soto
David Greenhalgh Paul Sundaram
David Lea-Smith Paula Daza-Navarro
Davide Barbagallo Paulo J. Palma
Davide Bizzoca Paulo Santiago
Davide Borroni Pavel Makarevich
Davut Karayel Pavel Rehak
De Gong Pawan Kumar
Debarati Paul Pedro Gomes
Deborah Verran Pedro Morouço
Deepti Shrivastava Peer Kämmerer
De-Li Shi Perrey Stephane
Delly Ramadon Peter Fennema
Dengfeng Li Peter Gaengler
Despina Kalogianni Peter Liddle
Devanand Venkatasubbu Gopinath Peter Mukli
Dhiraj Bhatia Peter Neubauer
Dianbao Zhang Peter Piko
Diego Romano Perinelli Peter Trosan
Dieter Dirksen Petr Masliukov
Dilovan Zebari Philip Hublitz
Dimitrios Tzachanis Philip Moore
Dinesh Veeran Ponnuvelu Philippe Gorce
Dirk Henrich Pichad Khejornsart
Dmitry Gryadunov Pier Nicola Sergi
Dmitry Kiselev Piero Antonio Zecca
Dmitry Markov Pietro Hiram Guzzi
Domenico Spinelli Ping Wang
Dominik Dłuski Pingfan Hu
Domonkos Varga Piotr Dobrowolski
Donatella Delle Cave Piotr Karauda
Dong Zhang Piotr Kurcok
Don-Gey Liu Piya Temviriyanukul
Dongrui Ma Piyush Baindara
Dongwoo Kim Pradeep Panda
Dong-Wook Han Priti Prasanna Maity
Dora Luz Almanza Ojeda Qaiser Riaz
Dragana Gabric Qi Shao
Dragana Zagorac Qian Ma
Drago Beslo Qian Wang
Dragos Apostu Qiang Peng
Dulani Meedeniya Qianrong Qi
Ebrahim Karami Qiao Lin
Ebrahim Kouhsari Qiguo Rong
Ebtesam Al-Suhaimi Qin Xiang Ng
Eduardo Nakano Qing Feng
Ekaterina Naumenko Qinhe Zhang
Elamparuthi Ramasamy Qiuyun Xu
Elena Helerea Rachid Touzani
Elena Salernitano Rade M. Babić
Elena Tchetina Radian Popescu
Eleuterio A. Sánchez Romero Radu Racovita
Elham Asgari Rafał Bachorz
Elisa Belluzzi Raghvendra Pratap Singh
Elisa Viladés Rahul Mandal
Elnaz Pashaei Rajagopal Maheswar
Elsa Chan Rajamani Devaraj
Elsa Marisa Vieira Rajiv Singla
Eman Mehanna Rajni Verma
Emanuela Chiarella Raluca Nicu
Emanuele Piuzzi Ramasubba Reddy Palem
Emanuele Torti Ramgopal Kashyap
Emerson Venancio Rami Suleiman
Enrique Berjano Rana Youness
Enrique Cuan-Urquizo Ratna Kishore Velamati
Enwu Liu Ravichandran Manickam
Erfan Tirkolaee Ravindra Kumar
Eric Chappel Rayaz A. Malik
Eric Fujiwara Rebekka Heitmar
Eric Goulet Récsán Zsuzsa
Eric Ramirez Reinaldo Rodríguez-Ramos
Erik Steen Redeker Remington L. Nevin
Erika de Alvarenga Renato Melo
Erman Çakıt Reza Razaghi
Esra Imamoglu Ricardo Cartes
Eugene Loos Riccardo Beltrami
Eugenio Mattei Ripon Sarkar
Eugenio Vocaturo Rita Cordeiro
Eui Chul Lee Rob Fowkes
Evangelia Sarantopoulou Robert Friedman
Everaldo Silvino dos Santos Robert W. Caldwell
Evgeny Mirkes Roberto Castiglione
Ewa Korzeniewska Roberto de Fazio
Ewa Oledzka Roberto Gatta
Ewa Piątkowska Rodolfo Reda
Fábio Fernandes Rogerio Buchaim
Fábio Lanferdini Ronald Moore
Fabrizio Barberis Roong Jien Wong
Fabrizio Fiori Roozbeh Abedini-Nassab
Facundo Almeraya-Calderón Rosalinda Inguanta
Fahad Ahmad Roseline Ogundokun
Fahim Sufi Rosella Cataldo
Fahmi Khalifa Rossella Cacciola
Faming Wang Rubén San-Segundo
Farhad Ali Ruchire Eranga Wijesinghe
Farkhondeh Asadi Runwen Yao
Fateh Mebarek Oudina Runze Li
Fatemeh Khatami Rupesh Kumar Chikara
Fausta Lui Ryan Peterson
Federico Barrino Ryota Hosomi
Federico Berton Saadullah Abbasi
Federico Solla Sadaf Bashir Khan
Feng Li Sadiq Abdulhussain
Feng Ma Saeed Roshani
Fengjie Zhao Saima Imran
Fengyuan Zhao Salil Bharany
Fernanda Lopes Salvatore Giordano
Fernanda Medeiros Borsagli Salvatore Saccone
Fernanda Mesquita Saman Parvaneh
Fernanda Tonelli Samet Memiş
Fernando Sanchez Lasheras Samo Fokter
Fidelis Ajibade Samuel Samnick
Filipe Pinto Samuele Sutera
Filippo Cademartiri Samy Sayed
Filomena Salazar Sandeep Kumar Mishra
Florian Recker Sandeep Urandur
Francesca Zotti Sanika Suvarnapathaki
Francesco Claps Sanjay Kumar Singh
Franco Zanini Sara Abdelsalam
Frank A. Schildberg Saravanan Ramiah Shanmugam
Frederico Vieira Sarfaraz Niazi
Fredrik Huss Satoshi Yamaguchi
G.P Ramesh Satyendra Tiwary
Gábor Hornyánszky Saurabh Sharma
Gabriel-Ionut Plavan Savvas Lampridis
Gador Canton Sebastian Glowinski
Gagandeep Singh Sebastiano Cicco
Galina Kurlyandskaya Sergey Kolotilov
Gang Chen Sergey Tkachev
Gang Li Sergii Babichev
Gary Garcia Molina Serkan Yílmaz
Gema Navarrete Sezer Okay
Gemma Palazzolo Shahjada Selim
Genki Yoshikawa Shahrokh Hatefi
George Fragulis Shahzadi Tayyaba
George Livanos Shaik Gouse Peera
George Manis Shailendra Maurya
George Paraskevas Shaobin Wang
George Thompson Shaode Yu
George Verros Shao-Yi Hsia
Georgios Panos Shenghong He
Ghada Atteia Allah Shichao Ding
Gian Andrea Pelliccioni Shigeki Kamitani
Gianandrea Pasquinelli Shikha Sharma
Giancarlo Condello Shilin Liu
Gilbert Lim Shireesh Srivastava
Giner Alor-Hernández Shiv Dutt Purohit
Giou-Teng Yiang Shiwei Liu
Giovanni Buzzaccarini Shoushui Wei
Giovanni Diraco Simon Fox
Giovanni Levi Simona Ascanelli
Giulia Festa Singara Singh Kasana
Giuseppe Brunetti Siu Hong Dexter Wong
Giuseppe Cirillo Sivakumar Nuvvula
Giuseppe Milone Sivarao Subramonian
Giuseppe Trusso Sfrazzetto Sivasakthivel Ramkumar
Glauco Chisci Siyuan Zhao
Gloria Cerasela Crisan Sladjana Stajčić
Gopichandh Danala Slawomir Jakiela
Gordana Wozniak Knopp Sohail Mumtaz
Gordon Alderink Solomon Viswas Raja
Gregory Chagnon Somdutt Mujwar
Grzegorz Cieślar Somenath Chakraborty
Grzegorz Sobota Sonia Ronchey
Grzegorz Zieliński Sophie Alvarez
Guankui Wang Sorin J. Brull
Gurkan Bayar Sorina Dinescu
Gurmail Paddan Sotiria Vrouva
Gustavo Costa Sotirios Kalfas
Gustavo Fernandes Soumya Basu
Haidi Ibrahim Soumya Nayak
Haishan Zeng Soumya Srivastava
Haiyan Yang Sourav Banerjee
Hajime Hajime Srijit Das
Hamed Barabadi Srikanth Prabhu
Hamed Hatami-Marbini Stefan Fischer
Hamed Nosrati Stefan Kranz
Hamed Taherdoost Stefano Di Paolo
Hamid Ghasemi Stefano Restaino
Hamid Tebyaniyan Stephan Havemann
Hanrui Wang Steven Murray
Hanseob Jeong Sudarsu Venkata Ramanaiah
Hans-Jürgen Federsel Sudi Patel
Hao Wu Sulev Kõks
Hao Zhang Suman Lama
Haradhan Kolya Suparerk Janjarasjitt
Harikumar Rajaguru Supriyo Ray
Hariprasath Manoharan Surendra Sarsaiya
Hartmut F. Witte Suresh Anand Sadananthan
Hasan Zulfiqar Syed Furqan Qadri
Haw-Ming Huang Syed Muzahir Abbas
Hayes Phil Syoichi Tashiro
He Zhang Tadeusz Mikolajczyk
Hemali Rathnayake Taha Mastura Mohammad
Hemangi Bhonsle Tahereh Jafary
Heng Bo Jiang Taj Mohammad
Henrique Neiva Takahiro Wada
Henry Atkinson Takaomi Arai
Hervé Reychler Takeharu Tsuge
Hesham Moustafa Takuya Koie
Hiam Alquran Tamás Haidegger
Hisao Haniu Taner Sar
Hong Tang Taner Tuncer
Hongqing Yu Tania Colasanti
Hongyu Ren Tarek Mohamed
Hooman Shafaee Tarik Kivrak
Hossam Nabwey Tatiana Rakitina
Huihua Yuan Teruya Komatsu
Hunter Moseley Thach Nguyen
Hyeuknam Kwon Thanavel Rajangam
Iacopo Cappellini Thayne Kowalski
Ignacio Bosch Thierry Ribeiro
Igor Gruic Thomas Boland
Igor Vujović Thomas Dippong
Ihsan Hamawand Thomas Lindner
Ilaria Cacciotti Thorsten Kuczius
Ilaria Girolami Tiago Ribeiro
Ilaria Marcantoni Tianming Zhao
Ilya Klabukov Tirath Raj
Iman Yazdi Tohru Yamada
Imtiaz Ahmad Tomasz Marciniak
Inbarasan Muniraj Tomasz Szymborski
Inderbir Singh Tommaso Greco
Indrajeet Kumar Tomohiro Torii
Ines Aguinaga-Ontoso Tomomi Yamazaki
Ioan Petean Tongran Qin
Ioan Tudosa Torbjörn Ledin
Ioannis Kosmas Torsten Malm
Ioannis Tsoulos Toshiyo Tamura
Ion Cosmin Puia Tugay Ayasan
Ionel Alexandru Checherita U. Vijayalakshmi
Ionut Schiopu Ugo D'Amora
Iqram Hussain Umapathi Reddicherla
Irena Jekova Usman Ghafoor
Irene Buj-Corral Vadim Elagin
Irene Chiesa Vaidotas Marozas
Irfan Khan Valeria Allizond
Irina Le-Deygen Vangelis Daskalakis
Irina Negut Vangelis Karalis
Ismail Ben Abdallah Vasil Garamus
Ismail Fidan Vassilios Papadopoulos
Ítala Marx Venkata Krishna Kowthavarapu
Iurii Krak Venugopal Rao Soma
Ivan Bratchenko Vesna Mandic-Markovic
Ivan Cuk Viacheslav Voronin
Ivan Ivanov Vikram Dalal
Ivo Dumic-Cule Viktoriya Davydova
Ivona Bago Vinay Shivanna
Jabar H. Yousif Vinay Vakharia
Jacopo Lamanna Vincenzo Taormina
Jaganmay Sarkar Vineet Kumar
Jaison Jeevanandam Vinoth Kumar
Jakub Szabelski Vítor Carvalho
James Chow Vittorio Rampa
James Chung-Wai Cheung Vivek Chavda
Jamshed Iqbal Vladimir Galaktionov
Jamshid Piri Voula Georgopoulos
Jan Gajewski Vrinda Gote
Janusz Kluczynski Vyacheslav Ryabov
Jaroslava Halper Wacław Kuś
Javad Hassannataj Joloudari Wansu Park
Javed Ali Khan Warawut Chaiwong
Javier Martin Weerawat Limroongreungrat
Jayshri Kulkarni Wei Feng
Jean-Michel Guenet Wei Yan
Jeanne Wilson-Rawls Weihua Huang
Jeffrey Jones Weihua Yang
Jennifer Gubitosa Weiping Li
Jeong Yeon Kim Weizhen Hou
Jesús Pastor Wen Shi
Jeyasakthy Saniasiaya Wenbin Shi
Ji Young Cho Wendy Bollag
Jia Wen Wenguang Yang
Jiacheng Zhang Wenji Piao
Jianan Zhao Wenjie Zhou
Jianhua Wu Wenjing Ma
Jianqi Wang Wenqiang Wei
Jie Wang William Berg
Jie Zhang Wim Buijs
Jihoon Moon Wito Richter
Jiling Feng Wi-Young So
Jilong Liu Woo-Jong Kim
Jimmy T. Efird Xavier Navarro
Jin Li Xiaobo Li
Jingan Li Xiaobo Wu
Jingjing Yang Xiaodong Zhou
Jingyi Xue Xiaohu Zhao
Jin-Hyuck Park Xiaolei Peng
Jinjun Xia Xiaoqiang Zhang
Jinkun Geng Xiaowei Zhang
Jinlong Liu Xiaoyang Guan
Jintamai Suwanprateeb Xiaoyang Liu
Jinwei Xie Xin Guo
Jinze Xu Xin Song
Joao Carmo Xin Tong
João Marcelo Teixeira Xingchun Gao
João Paulo Tribst Xinjun Feng
Joaquim Carreras Xinyu Ling
Jochen Salber Xuan Mu
Jochen Schmid Xudong Ji
Jochen Winter Xuejun Liu
John A. StCyr Xueming Zhang
John Ayeelyan Xueqin Gao
John M. Perry Yang Zhang
John Nicholson Yanru Lou
John Stanford Yaoxiang Li
Jolanta Szymańska Yasemin M. Akay
Jonas Kurniawan Yekta Can
Joni H. Ylostalo Yeliz Karaca
Jorge Arede Yeong-Min Yoo
Jorge Grasa Yi Wang
Jorge Ordonez-Llanos Yi Zhang
José Francisco González Prieto Yide Zhang
Jose L. Martinez-de-Juan Yifan Ma
Josefa Gonzalez-Santos Yi-Lang Chen
Joseph Christakiran Moses Yin Zhao
Jovan Gardasevic Ying Yang
Jozsef Sarosi Yingji Mao
Juan Manuel Belda Lois Yinglei Song
Juan Manuel Gutiérrez Yizhang Wu
Juan Shan Yoo Tanabe
Juern W. P. Schmelzer Yosra Soltan
Julius Höhne Young Hye Song
Juliusz Huber Young Zoon Kim
Jun Long Lim Yu Knyazev
Junaidi Khotib Yu Zhang
Jung Woo Sohn Yuan-Yang Cheng
Juris Burlakovs Yu-Chi Lee
Juvenal Rodriguez Yufang Shen
Jwayoung Kim Yukun Yang
Kai Bin Liew Yulia Alexandrovskaya
Kai Li Yun Ling
Kailing Yu Yunn-Hwa Ma
Kamalan Kirubaharan Amirtharaj Mosas Yuxin Tong
Kamil Reza Khondakar Yves Bayon
Kamyar Khoshnevisan Zaihua Duan
Karel Kostev Zapryana Denkova
Kari Stone Zhaoxi Sun
Karim Kriaa Zhen Wang
Katarzyna Krukiewicz Zhengwei Huang
Katrin Bauer Zhengzhi Mu
Kavitha Subash Zhengzhong Tan
Kayode Oshinubi Zhibin Zhou
Ke Cheng Zhiguo He
Keigi Fujiwara Zhijie Wang
Kelin Du Zhiping Liu
Kelly De Jesus ZhuangJian Liu
Kenichi Kimura Zhuhuang Zhou
Kenji Hayashida Zhuofu Liu
Kenneth Lim Zia Ullah Arif
Kevin Dzobo Zihao Ding
Khaled Aboshanab Zihao Ou
Khalid Raza Zizhu Zhang
Kijoon Lee Zsolt Piróth
Kim Jin-Chul Zygmunt Pojda

2 January 2024
MDPI Insights: The CEO's Letter #7 - Nobel Laureates Entrust MDPI with Their Research

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Nobel Prize Laureates Entrust MDPI with Their Research

The Nobel Prize stands as a hallmark of distinction, honouring ground-breaking research across disciplines. Annually, the Nobel Prizes are awarded in six categories: Physics, Chemistry, Medicine or Physiology, Literature, Peace, and Economic Sciences.

Through the years, renowned scholars have entrusted MDPI with their work. As at December 2023, 26 Nobel laureates have contributed to more than 75 articles across 25 MDPI journals, including: Antibiotics, Applied Sciences, Biology, Biomedicines, Cancers, Catalysts, Cells, Crystals, Entropy, Games, IJMS, Life, Materials, Micromachines, Molecules, Pharmaceuticals, PharmaceuticsPhotonics, Quantum Beam Science, Remote Sensing, Sensors, Solids, Universe, Vaccines, and Viruses.

The best of the best trust us with their work.

Nobel Prize Laureates Who Have Published with MDPI

We are proud to list the names of Pierre Agostini, Hiroshi Amano, Werner Arber, Aaron Ciechanover, Robert H. Grubbs, Oliver Hart, Gerard ‘t Hooft, Michael Houghton, Harald zur Hausen, Katalin Karikó, Jean-Marie Lehn, Gérard Mourou, Ferid Murad, Shuji Nakamura, William Nordhaus, Kostya S. Novoselov, Giorgio Parisi, Charles M. Rice, Alvin E. Roth, Donna Strickland, K. Barry Sharpless, George F. Smoot, Anne L’Huillier, Drew Weissman, Kurt Wüthrich, Ada Yonath.

The privilege of hosting such contributors resonates deeply with our editorial teams. For instance, in this interview, the Editor-in-Chief (EiC) of Universe speaks on the significance of publishing a paper by Nobel laureate Gerard ’t Hooft within the journal.

2023 Nobel Prize Winners Published by MDPI

Nobel Prize Winners, 2023: Katalin Karikó, Drew Weissman, Anne L’Huillier (Ill. Niklas Elmehed © Nobel Prize Outreach)

Three laureates from the 2023 Nobel Prize cohort have trusted MDPI as their publishing platform. Notably, in a 2022 Pharmaceutics paper, molecular biologist Katalin Karikó and her team presented a methodology for evaluating mRNA capping efficiency, pivotal for therapeutic applications. Pharmaceutics had previously dedicated a Special Issue to “mRNA Therapeutics: A Themed Issue in Honor of Professor Katalin Karikó”, spotlighting ten articles from August 2021 to February 2022.

In the journal Vaccines, Professor Drew Weissman, collaborating with scholars from Pennsylvania University and George Mason University, contributed an influential review titled “Nanomaterial Delivery Systems for mRNA Vaccines”. His collaborative efforts spanned five papers across MDPI journals between 2021 and 2023.

Furthermore, Anne L'Huillier of Lund University, only the fifth female recipient of the Physics Prize, co-authored an article in Applied Sciences focusing on "Advanced EUV and X-Ray Optics". Similarly, Pierre Agostini, an Emeritus Professor from Ohio State University, co-authored an article featured in the special issue "Attosecond Science and Technology: Principles and Applications".

We extend heartfelt congratulations to all Nobel Prize laureates and express sincere gratitude for their confidence in MDPI as a platform for their scholarly contributions.

Read more:

Impactful Research

MDPI Journals Newly Indexed in 2023

The aim of indexing is to enhance the quality and credibility of published research, ensuring that researchers access the most credible resources available. While the principle behind citation indexing is straightforward, it remains one of the most dependable methods for tracking an idea's evolution across various scientific disciplines.

Throughout the year, MDPI works to expand the reach of our publications across premier multidisciplinary databases like Web of Science, Scopus, EBSCO, and ProQuest. This initiative is spearheaded by MDPI's Indexing team, under the leadership of Dr. Constanze Schelhorn.

In 2023, MDPI achieved 54 new acceptances in Scopus, 29 in Web of Science, 52 in EBSCO, and 83 in DOAJ: Directory of Open Access Journals.

The team prioritizes ensuring that our journals feature in numerous specialized databases, including PMC, PubMed, MEDLINE, Inspec, CAS, and FSTA, among others. Currently, MDPI collaborates with over 65 renowned international databases, consistently enhancing our database affiliations annually.

MDPI’s journals are indexed in all major global databases.

Furthermore, we collaborate with universities and government organizations to list our journals in country-specific ranking lists and relevant institutional repositories. This ensures compliance with requirements often set by funders or institutions for authors to publish in specific journals.

Web of Science Adds 24 MDPI Journals to Emerging Sources Citation Index (ESCI)

Clarivate recently analysed MDPI’s new journals, resulting in 24 journals, mainly established in 2020, being added to the ESCI in November and December 2023. Additionally, five journals passed this assessment earlier in the year. For a complete list of our journals in Web of Science, refer here. Journals in the ESCI meet 24 quality criteria, ensuring editorial rigor. They may be considered for inclusion in broader indices like the Science Citation Index Expanded (SCIE), the Social Sciences Citation Index (SSCI), or the Arts and Humanities Citation Index (AHCI), based on four impact criteria.

Read more:

Inside MDPI

MDPI Appoints New Chief Operating Officer (COO)

Alistair Freeland returned to MDPI and assumed the role of Chief Operating Officer in November 2023, a position he previously held from 2013 to 2019. He succeeds Dr. Yu Lin, who will remain a member of MDPI’s Board of Directors, overseeing significant financial decisions for the company. I would like to express my sincere thanks to Dr. Yu Lin for his service as COO.

Alistair brings extensive experience not only in scholarly publishing but also in technology and business management. Prior to rejoining MDPI, he was associated with SIX Group, the entity responsible for Switzerland's financial market infrastructure. There, he played a pivotal role in developing the blockchain-based platform SDX (SIX Digital Exchange), which has gained traction among major Swiss banks and the Swiss National Bank.

As COO, Alistair will collaborate with the MDPI management team to improve the practices and services we offer to scholarly communities. I am pleased to welcome Alistair back to MDPI and look forward to his contributions going forward.

Coming Together for Science

MDPI’s 2024 In-Person Academic Events Schedule

MDPI's Conference Team is dedicated to organizing and hosting in-person academic events across Europe, Asia-Pacific, and North America. We recognize conferences as invaluable platforms for scientific collaboration, scholarly exchange, discussions on contemporary topics, networking, and forging collaborations.

Here's a glimpse of the notable events we currently have scheduled for 2024:

14–16 February, 2024
Viruses 2024 – A World of Viruses
Location: Barcelona, Spain
We are honoured to feature Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes as keynote speakers for this 5th edition.
Event details

24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities 
Location: Barcelona, Spain
Esteemed speakers include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.
Event details

28–31 May, 2024
Polymers 2024 – Polymers for a Safe and Sustainable Future
Location:
Athens, Greece
We look forward to welcoming renowned experts like Prof. Damià Barceló, Prof. Minna Hakkareinen, and Prof. Armando J. D. Silvestre to this event.
Event details

1–4 August, 2024
The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science
Location: Singapore
The AI Sensors 2024 Conference will unite innovators and experts in the realms of sensors, sensing technology, and artificial intelligence.
Event details

Upcoming events with details to be announced:

  • September 2024, Materials 2024 – Basel, Switzerland
  • 1921 September 2024, International Conference on Nanomaterials Sciences 2024 – Beijing, China
  • October 2024, ncRNA 2024 – Basel, Switzerland
  • November 2024, Pharmaceuticals 2024 – Barcelona, Spain
  • 2226 November 2024, International Conference on Science of Electronics – Wuhan, China
  • Stay tuned for more details on the Sustainable Publishing Forum 2024.

Click here for all upcoming MDPI events.

Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

Reflecting on 2023 and Looking Ahead to 2024

As we approach 2024, I reflect on the incredible journey we’ve had together at MDPI this year. The past 12 months have been marked by ambitious projects and initiatives to improve our internal processes, and a commitment to continue delivering top-notch services to our stakeholders. I’d like to thank each and every one of our staff members for contributing to the positive experiences our stakeholders have reported in our surveys. Your dedication to speed, efficiency, and effective communication with our stakeholders is very much recognized and appreciated.

Becoming a stronger organisation

While we have encountered challenges in 2023, it’s important to understand that these are a part of our growth process. Difficulties provide us with opportunities to reflect, address problems at their roots, and ultimately evolve into a stronger organization. Our stakeholders expect us to overcome tough times, and it’s an expectation that we have for ourselves.

I extend my sincere appreciation to every MDPI employee, from our editorial office and IT department to marketing, indexing, IOAP, societies, Scientific Office board, products, production, conferences, finance, operations, admin, and beyond. To our newest team members, a warm welcome; to our longstanding colleagues, your dedication is invaluable.

“I am committed to taking MDPI to a new level of excellence.”

Interacting with many of you during my visits to our offices and representing MDPI at external events has been a personal highlight. I am deeply grateful to Dr. Lin for entrusting me with the role of CEO of MDPI. Looking forward, I am committed to working closely with our management team to lead MDPI and take it to a new level of excellence, aiming to establish it as the most trusted publisher in open access worldwide. This is a collective endeavour, with each of us shaping MDPI’s reputation. I therefore encourage us to take pride in our work, as it represents not only our craft but also MDPI as a whole.

Accountability and communication

As we look forward to 2024, there’s a lot to be excited about. Together, we’ll navigate challenges, seize growth opportunities, and refine our practices. To solidify MDPI’s position as the premier open access publisher globally, we must bolster accountability, improve stakeholder communication, share MDPI’s best practices, champion the open access philosophy, and educate stakeholders about our mission, methodologies, and motivations.

Thank you for engaging with the CEO Letter over the past six months of 2023. I will continue to release this newsletter as a method of sharing the great work being done at MDPI. Please feel free to connect directly with any insights or questions.

Here’s to a joyous and prosperous 2024!

Stefan Tochev
Chief Executive Officer
MDPI AG

Back to TopTop